Our top pick for
Building a portfolio

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Apex Technology Acquisition Corporation is a shell companies business based in the US. Apex Technology Acquisition Corporation shares (APXT) are listed on the NASDAQ and all prices are listed in US Dollars.
Our top pick for
Building a portfolio
Our top pick for
Beginners
Our top pick for
Active traders
52-week range | $9.63 - $17.90 |
---|---|
50-day moving average | $12.08 |
200-day moving average | $12.81 |
Wall St. target price | N/A |
PE ratio | N/A |
Dividend yield | N/A (0%) |
Earnings per share (TTM) | N/A |
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -0.98% |
Return on equity TTM | -85.02% |
Profit margin | 0% |
Book value | N/A |
Market capitalisation | $509.8 million |
TTM: trailing 12 months
There are currently 2.4 million Apex Technology Acquisition Corporation shares held short by investors – that's known as Apex Technology Acquisition Corporation's "short interest". This figure is 13.4% up from 2.1 million last month.
There are a few different ways that this level of interest in shorting Apex Technology Acquisition Corporation shares can be evaluated.
Apex Technology Acquisition Corporation's "short interest ratio" (SIR) is the quantity of Apex Technology Acquisition Corporation shares currently shorted divided by the average quantity of Apex Technology Acquisition Corporation shares traded daily (recently around 1.1 million). Apex Technology Acquisition Corporation's SIR currently stands at 2.22. In other words for every 100,000 Apex Technology Acquisition Corporation shares traded daily on the market, roughly 2220 shares are currently held short.
However Apex Technology Acquisition Corporation's short interest can also be evaluated against the total number of Apex Technology Acquisition Corporation shares, or, against the total number of tradable Apex Technology Acquisition Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Apex Technology Acquisition Corporation's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Apex Technology Acquisition Corporation shares in existence, roughly 50 shares are currently held short) or 0.0674% of the tradable shares (for every 100,000 tradable Apex Technology Acquisition Corporation shares, roughly 67 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Apex Technology Acquisition Corporation.
Find out more about how you can short Apex Technology Acquisition Corporation stock.
We're not expecting Apex Technology Acquisition Corporation to pay a dividend over the next 12 months.
Apex Technology Acquisition Corporation does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the software and internet technology industries. The company was incorporated in 2019 and is based in Burlingame, California. Apex Technology Acquisition Corporation is a subsidiary of Apex Technology Sponsor LLC. .
Everything we know about the Talaris Therapeutics IPO, plus information on how to buy in.
Everything we know about the Sagimet Biosciences IPO, plus information on how to buy in.
Everything we know about the Zenvia IPO, plus information on how to buy in.
Everything we know about the Grove IPO, plus information on how to buy in.
Everything we know about the Pasithea Therapeutics IPO, plus information on how to buy in.
Features, fees and complaints to consider before you apply for a T. Rowe Price account.
Steps to owning and managing ZTO, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZOM, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZI, with 24-hour and historical pricing before you buy.
Steps to owning and managing ZKIN, with 24-hour and historical pricing before you buy.